- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03343730
RetinaVue Diabetic Screening
Diabetic Retinopathy Screening With Non-mydriatic Color Fundus Camera in the Primary Care Clinic
Study Overview
Status
Conditions
Detailed Description
The Centers for Disease Control and Prevention (CDC) have estimated that 25.6 million Americans aged 20 years or older have either been diagnosed or undiagnosed with diabetes mellitus. As such, it is crucial for patients to receive routine eye exams during their annual health assessment or diabetes follow-up visit with their primary care physician to check for diabetic retinopathy (DR). Of those Type 2 patients with a known duration of diabetes of less than 5 years, DR was diagnosed in 40% of patients taking insulin and 24% of patients not taking insulin. These percentages are especially concerning since data presented by Schoenfeld and colleagues indicates that approximately 35% of Americans with diabetes mellitus do not receive timely and recommended eye care to detect and treat their DR.10 Reasons for noncompliance include transfer to a retinal specialist, limited personal mobility, and insurance. In addition, patients regularly fail to follow-up with their ophthalmologist or optometrist due to the lack of visual symptoms-the lack of symptoms does not exclude the possibility of early diabetic retinopathy. Per the American Diabetes Association (ADA) guidelines, it is recommended that all Type 2 patients receive annual dilated eye exams. These eye exams must be completed by a knowledgeable and experienced eye care professional (i.e. ophthalmologist or optometrist). Early detection of DR and the preventative effects of therapy is an important aspect for long term vision outcomes.
The long-term goal is to improve the detection of diabetic retinopathy through better-quality measures of patient compliance and screening protocols in the prime care clinic. It is hypothesized that in type II diabetic patients without documented retinal pathology, a hand-held non-mydriatic fundus camera is superior to a referred dilated eye exams for the screening and detection of DR.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Julie Tirrell, RN
- Phone Number: 6075476563
- Email: julie.tirrel@bassett.org
Study Locations
-
-
New York
-
Cooperstown, New York, United States, 13326
- Recruiting
- Bassett Medical Center
-
Principal Investigator:
- james dalton, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 18 years
- Type II diabetes without documented diabetic retinopathy
Exclusion Criteria:
- Documented ocular pathology that may interfere with image acquisition (i.e. high grade cataract)
- Macular pathology (i.e. macular degeneration, cystoid macular edema, central serous retinopathy)
- Inability to attain analyzable RetinaVue image due to ocular pathology or other conditions (such as tremors limiting ability to maintain stable head for image)
- Acute or emergent ocular pathology that requires urgent assessment by an eye care professional as identified by the RetinaVue camera interpretation report
- Seen within the last 11 months for a diabetic eye exam.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SCREENING
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Non-mydriatic color fundus photography
All participants will receive Non-mydriatic color fundus photography with the RetinaVue camera at an already scheduled annual physical exam or follow up clinic visit with their primary care provider (PCP).
|
This hand-held device allows the primary care physician to capture an image of the patient's retina and transmit the image to a board-certified ophthalmologist for interpretation.
|
ACTIVE_COMPARATOR: Standard of Care (Control)
All patients will also receive a referral for a dilated eye exam with an eye care professional.
A yearly dilated exam as referred by the PCP.
|
All patients will be given a referral to an eye care professional for a routine, dilated, diabetic eye exam.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Diabetic Retinopathy Detection
Time Frame: 3 months
|
This study will examine the rate of detection of diabetic retinopathy using an in-clinic retinal camera and standard referral to eye care professional for dilated eye exam
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: james Dalton, MD, Bassett Medical Center
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2078
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Retinopathy
-
Retina Institute of HawaiiUnknownDiabetic Macular Edema | Proliferative Diabetic Retinopathy | Severe Nonproliferative Diabetic Retinopathy | Mild Nonproliferative Diabetic Retinopathy | Moderate Nonproliferative Diabetic RetinopathyUnited States
-
University of CataniaUnknownProliferative Diabetic Retinopathy | Non Proliferative Diabetic RetinopathyItaly
-
Asociación para Evitar la Ceguera en MéxicoCompletedProliferative Diabetic Retinopathy | Severe Nonproliferative | Active Photocoagulated Diabetic RetinopathyMexico
-
Asociación para Evitar la Ceguera en MéxicoUnknownProliferative Diabetic Retinopathy | Non Proliferative Diabetic RetinopathyMexico
-
Valo Health, Inc.RecruitingProliferative Diabetic Retinopathy | Non-proliferative Diabetic RetinopathyUnited States
-
Asociación para Evitar la Ceguera en MéxicoUnknownNon Proliferative Diabetic Retinopathy. | Proliferative Diabetic Retinopathy.Mexico
-
AEYE Health IncA. Stein Regulatory Affairs Consulting Ltd.RecruitingDiabetic Mellitus | Diabetic Retinopathy, DRUnited States
-
Ocuphire Pharma, Inc.CompletedDiabetic Retinopathy | Diabetic Macular Edema | NPDR - Non Proliferative Diabetic Retinopathy | PDR - Proliferative Diabetic RetinopathyUnited States
-
King Khaled Eye Specialist HospitalCompletedDiabetic Macular Edema | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic RetinopathySaudi Arabia
-
Retina Macula InstituteAllerganCompletedDiabetic Macular Edema | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic RetinopathyUnited States
Clinical Trials on Non-mydriatic color fundus photography with the RetinaVue camera
-
Pakistan Council of Scientific and Industrial ResearchAl-Ibrahim Eye HospitalRecruiting
-
URAL Telekomunikasyon San. Trade Inc.Not yet recruiting
-
The Filatov Institute of Eye Diseases and Tissue...Komisarenko Institute of Endocrinology and Metobolism; CheckEye LLCRecruiting
-
Eyenuk, Inc.National Eye Institute (NEI)CompletedDiabetic RetinopathyUnited States
-
Eyenuk, Inc.Completed
-
Eyenuk, Inc.National Eye Institute (NEI)CompletedDiabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye ProblemsUnited States
-
URAL Telekomunikasyon San. Trade Inc.RecruitingGlaucoma | Eye Diseases | Age-Related Macular Degeneration | Diabetic Retinopathy | Diabetic Macular Edema | Retinal Vein OcclusionTurkey
-
RETINA-AI Health, Inc.CompletedDiabetes | Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye ProblemsUnited States
-
URAL Telekomunikasyon San. Trade Inc.Akdeniz UniversityRecruitingDiabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye ProblemsTurkey
-
Mantis Photonics ABBlekinge County Council Hospital; Blekinge Institute of TechnologyNot yet recruitingCognitive Impairment | Cognitive Decline | Alzheimer Disease, Early OnsetSweden